Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
NUWE Nuwellis
- 1.060
- +0.030+2.88%
Close May 2 16:00 ET
- 1.031
- -0.029-2.75%
Post 16:12 ET
4.64MMarket Cap-0.13P/E (TTM)
1.080High1.000Low72.29KVolume1.040Open1.030Pre Close75.33KTurnover1.65%Turnover RatioLossP/E (Static)4.37MShares12.60052wk High0.71P/B4.64MFloat Cap0.75152wk Low--Dividend TTM4.37MShs Float6085800000.000Historical High--Div YieldTTM7.77%Amplitude0.751Historical Low1.042Avg Price1Lot Size
About Nuwellis Company
Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.
Company Profile
SymbolNUWE
Company NameNuwellis
Listing DateFeb 16, 2012
Founded1999
CEOMr. John L. Erb
MarketNASDAQ
Employees38
Fiscal Year Ends12-31
Address12988 Valley View Road
CityEden Prairie
ProvinceMinnesota
CountryUnited States of America
Zip Code55344
Phone1-952-345-4200
Company Executives
- Name
- Position
- Salary
- John L. Erb
- Chairman of the Board, Interim Chief Executive Officer and President
- 49.30K
- Robert Benjamin Scott
- Chief Financial Officer and Principal Accounting Officer
- 269.96K
- Neil P. Ayotte, Esq.
- Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
- 306.99K
- Michael McCormick
- Independent Director
- 72.61K
- Gregory D. Waller
- Independent Director
- 53.41K
- David Alan McDonald
- Independent Director
- 54.35K
- Dr. Maria Rosa Costanzo, M.D.
- Independent Director
- 41.08K
- Dr. Archelle Georgiou, M.D.
- Independent Director
- 56.40K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
